# 2-AG as a potential biomarker for predicting response to short-term fluoxetine treatment in a mouse model of depression

Source: [Biological sciences : nature.com subject feeds](https://www.nature.com/articles/s41398-026-04548-8) · 2026-11-13 · Life
Page: https://themorning.science/story/2-ag-as-a-potential-biomarker-for-predicting-response-to-short-term-fluoxetine-t-3fa4075f0ccfe46a
Kind: research · Impact: low

## In brief

- A study reports serum 2-AG as a potential biomarker for predicting response to short-term fluoxetine treatment in a mouse model of depression.
- The finding is from a mouse model and has not been shown in humans based on the provided sources.
- The source is a nature.com subject feed entry dated 2026-11-13 with no summary available.

## Why it matters

If validated, a blood-based marker could help predict which patients respond to antidepressants, but the evidence here is limited to a mouse model.

## Timeline

- 2026-11-13: Study listed in nature.com subject feed

## Coverage

- [2-AG as a potential biomarker for predicting response to short-term fluoxetine treatment in a mouse model of depression](https://www.nature.com/articles/s41398-026-04548-8) — Biological sciences : nature.com subject feeds, 2026-11-13

Tags: depression, fluoxetine, biomarker, endocannabinoid, mouse model

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science